Molecular magnetic resonance imaging of atherosclerotic vessel wall disease.

Dominik NörenbergHans U EbersbergerGerd DiederichsBernd HammRené M BotnarMarcus R Makowski

Published in: European radiology (2015)

Targeted MR-probes allow the characterization of atherosclerosis on a molecular level. Molecular MRI can identify in vivo markers for the differentiation of stable and unstable plaques. Visualization of early molecular changes has the potential to improve patient-individualized risk-assessment.

Keyphrases

magnetic resonance imaging
risk assessment
contrast enhanced
single molecule
computed tomography
small molecule
human health
heavy metals
photodynamic therapy
living cells